Stempoint Capital’s Inventiva IVA Stock Holding History

Stempoint Capital’s Portfolio IVA Stock Details IVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-467,242	Closed	-$2.17M	–	100
2025 Q4	$2.17M	Buy	467,242 +436,418	+1,416%	+$2.03M	0.37%	57
2025 Q3	$178K	Buy	+30,824	New	+$134K	0.04%	79

Other funds holding IVA

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $437M AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCP

SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Stempoint Capital's IVA Position: Q1 2026 in Review

Stempoint Capital sold out of Inventiva (IVA) in Q1 2026, closing a stake of 467,242 shares — an estimated $2.17M sold.

Stempoint Capital first reported a position in IVA in Q3 2025 and held it in 2 quarters. The position peaked at $2.17M in Q4 2025. 65 funds tracked by Wall St. Rank hold IVA as of Q1 2026.

Stempoint Capital reported no remaining Inventiva position as of Q1 2026 after selling out during the quarter.
Stempoint Capital sold 467,242 Inventiva shares in Q1 2026, an estimated $2.17M.
Stempoint Capital first reported a position in Inventiva in Q3 2025 and held it in 2 quarters.
Stempoint Capital's Inventiva position peaked at $2.17M in Q4 2025.
65 funds tracked by Wall St. Rank held Inventiva as of Q1 2026.

Based on Stempoint Capital's 13F filing for Q1 2026, filed 15 May 2026.